Google+
 
j Andreas 47
Kontakt Andreas 47 Drucken

Mein Bericht

Übersetzen auf:
Deutsch    
Französisch    
Spanisch    

Datum Δ 

letzter PSA vom

Erfahrungsberichte

       
24.07.2014 6.16 24.07.14
High PSA level detected during annual medical check (even though the two earlier years levels where also already high for my age, but still below 4).
       
04.08.2014 8.75 04.08.14
Follow-up PSA check at urology department of Japanese Red Cross Medical Center. Free PSA: 15%. MRI is scheduled for 21.8.2014.
       
01.09.2014 5.92 01.09.14
MRI findings: prostate cancer in the right lobe, suspected. Free PSA: 12%. Biopsy is recommended.
       
18.11.2014 8.36 18.11.14
Free PSA 11%. Upon my request to rule out a prostatitis, the antibiotic Cravit is prescribed for 14 days.
       
09.12.2014 7.28 09.12.14
PSA value is still high and free PSA at 12% after antibiotic treatment. Scheduling another MRI at Alta-Klinik in G├╝tersloh, Germany for 22.12.2014.
       
22.12.2014 5.19 22.12.14
MRI findings: suspicious regions in both lobes, MRI-guided biopsy scheduled for the next day.
       
05.01.2015 5.19 22.12.14
Laboratory result of the six core needle biopsies: the presence of a carcinoma with a Gleason score of 6 (3+3) in the proximal third of the peripheral zone of the left lateral lobe of the prostate gland; the presence of atypical adenomatous hyperplasia (AAH) in the middle of the peripheral zone of the left lateral lobe; and the presence of pre-malignant high-grade PIN in the distal third of the peripheral zone of the left lateral lobe. The examination also indicates: the presence of a carcinoma with a Gleason score of 7 [3+4 (5%)] in the middle third of the peripheral zone of the right lateral lobe of the prostate gland; the presence of a carcinoma with a Gleason score of 7 [3+4 (10%)] in the distal third of the peripheral zone of the right lateral lobe.
Radical Prostatectomy suggested.
       
02.02.2015 5.86 02.02.15
While visiting several medical centers in Japan offering proton therapy to collect information, I submit the biopsy samples to Dr. Tsujii, a fellow of the National Institute of Radiological Sciences in Chiba, Japan for second opinion, and visit the Cancer Institute Hospital of JFCR (Japanese Foundation of Cancer Research), who places me on Active Surveillance. MRI is scheduled for 1.6.2015. In addition it is suggested to refrain from eating meat, especially red meat. After further research I change my diet to exclude any meat (with the exception of fish) and dairy.
       
01.06.2015 6.42 01.06.15
MRI findings: the suspected area seems to have extended, and re-biopsy is scheduled for 5.8.2015.
       
13.08.2015 6.42 01.06.15
Laboratory result of the 16 core needle biopsies, including 2 targeted: no presence of carcinoma could be found in any of the 16 specimens. Follow-up PSA check is scheduled for 17.12.2015.
       
02.10.2015 3.88 02.10.15
During an unrelated blood test regarding a bacterial infection in my leg I ask for my PSA value, which turns out to have dropped below 4.
       
17.12.2015 5.29 17.12.15
Follow-up PSA check at the Cancer Institute Hospital of JFCR. Next PSA check is scheduled for 14.4.2016.
       
14.04.2016 4.88 14.04.16
Follow-up PSA check at the Cancer Institute Hospital of JFCR. Next PSA check is scheduled for 17.10.2016.
       
21.07.2016 4.08 21.07.16
PSA level measured during annual medical check at Japanese Red Cross Medical Center.
       
17.10.2016 5.33 17.10.16
Follow-up PSA check at the Cancer Institute Hospital of JFCR. Next PSA check is scheduled for 17.4.2017.
       
17.01.2017 5.39 17.01.17
PSA level measured during an unrelated blood test at St. Luke's International Hospital Tokyo.
       
17.04.2017 5.87 17.04.17
Follow-up PSA check at the Cancer Institute Hospital of JFCR. Next PSA check is scheduled for 30.10.2017.
       
27.07.2017 5.10 27.07.17
PSA level measured during annual medical check at Japanese Red Cross Medical Center.
       
21.09.2017 4.52 21.09.17
Follow-up PSA check at the Cancer Institute Hospital of JFCR. Next PSA check is scheduled for 22.3.2018.